Home / CAMRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CAMRF make money? Does CAMRF have pricing power? What's the Earnings Whisper? Will CAMRF profit more as the business scales? What is CAMRF's management track record? Is CAMRF's current price justified?

Camurus AB

$61.75 -$5.38 (-8.01%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$61.75

Day Range

$61.75$64

Year Range

$54$71

Market Cap

3.67B

AVG Volume

110

Trailing/Forward PE

52.15/2.97

PEG ratio

1.19

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

Other OTC

Revenue (SEK)

CAMRF Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q2	702.08M
26 Q1	531.29M
25 Q4	464.46M
25 Q3	563.17M
25 Q2	675.5M
25 Q1	558.34M
24 Q4	553.13M
24 Q3	479.6M
24 Q2	444.87M
24 Q1	389.99M

Net Income (SEK)

CAMRF Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q2	240.83M
26 Q1	143.33M
25 Q4	100.88M
25 Q3	191.32M
25 Q2	244.79M
25 Q1	197.25M
24 Q4	146.98M
24 Q3	129.35M
24 Q2	74.2M
24 Q1	77.86M

Operating Income (SEK)

CAMRF Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q2	292.5M
26 Q1	180.23M
25 Q4	112.78M
25 Q3	235.64M
25 Q2	292.05M
25 Q1	238.88M
24 Q4	166.07M
24 Q3	141.83M
24 Q2	82.61M
24 Q1	78.66M

EBITDA (SEK)

CAMRF EBITDA (SEK) by quarter
Period	EBITDA (SEK)
26 Q2	318.23M
26 Q1	187.09M
25 Q4	135.07M
25 Q3	251.4M
25 Q2	314.71M
25 Q1	260.94M
24 Q4	190.04M
24 Q3	169.24M
24 Q2	108.13M
24 Q1	100.83M

Cash Flows (SEK)

CAMRF Cash Flows (SEK) by quarter
Period	Cash Flows (SEK)
26 Q2	193.13M
26 Q1	122.27M
25 Q4	209.64M
25 Q3	129.02M
25 Q2	350.08M
25 Q1	38.34M
24 Q4	83.36M
24 Q3	144.59M
24 Q2	96.83M
24 Q1	34.7M

EPS (SEK)

CAMRF EPS (SEK) by quarter
Period	EPS (SEK)
26 Q2	4.05
26 Q1	2.4
25 Q4	1.67
25 Q3	3.19
25 Q2	4.08
25 Q1	3.29
24 Q4	2.45
24 Q3	2.17
24 Q2	1.25
24 Q1	1.32

Expenses (SEK)

CAMRF Expenses (SEK) by quarter
Period	Expenses (SEK)
26 Q2	398.85M
26 Q1	346.51M
25 Q4	355.22M
25 Q3	312.09M
25 Q2	363.72M
25 Q1	323M
24 Q4	368.61M
24 Q3	307.21M
24 Q2	326.39M
24 Q1	290.75M

Cash & Debt (SEK)

CAMRF Cash & Debt (SEK) by quarter
Period	Cash & Debt (SEK)
26 Q2	4.07B
26 Q1	3.86B
25 Q4	3.73B
25 Q3	3.49B
25 Q2	3.35B
25 Q1	2.88B
24 Q4	2.85B
24 Q3	2.75B
24 Q2	2.57B
24 Q1	2.27B

Debt ratios

CAMRF Debt ratios by quarter
Period	Debt ratios
26 Q2	-4.44
26 Q1	-4.22
25 Q4	-3.76
25 Q3	-3.33
25 Q2	-3.47
25 Q1	-3.81
24 Q4	-4.99
24 Q3	-7.57
24 Q2	-8.34
24 Q1	-3.87

Margins

CAMRF Margins by quarter
Period	Margins
26 Q2	93.71%
26 Q1	91.74%
25 Q4	92.17%
25 Q3	91.93%
25 Q2	93.91%
25 Q1	92.96%
24 Q4	93.98%
24 Q3	93.01%
24 Q2	92.01%
24 Q1	92.08%

Return on Capital

CAMRF Return on Capital by quarter
Period	Return on Capital
26 Q2	5.15%
26 Q1	3.25%
25 Q4	2.38%
25 Q3	4.68%
25 Q2	6.32%
25 Q1	5.66%
24 Q4	4.47%
24 Q3	4.16%
24 Q2	2.53%
24 Q1	2.94%

Shares Outstanding

CAMRF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	59.51M
26 Q1	59.44M
25 Q4	59.86M
25 Q3	59.68M
25 Q2	58.99M
25 Q1	58.88M
24 Q4	58.82M
24 Q3	59.36M
24 Q2	59.36M
24 Q1	57.25M

Book Value Per Share (SEK)

CAMRF Book Value Per Share (SEK) by quarter
Period	Book Value Per Share (SEK)
26 Q2	78.65
26 Q1	74.15
25 Q4	70.75
25 Q3	68.52
25 Q2	65.61
25 Q1	59.22
24 Q4	55.92
24 Q3	52.43
24 Q2	49.33
24 Q1	46.21

Total Assets (SEK)

CAMRF Total Assets (SEK) by quarter
Period	Total Assets (SEK)
26 Q2	5.31B
26 Q1	4.94B
25 Q4	4.74B
25 Q3	4.59B
25 Q2	4.42B
25 Q1	3.97B
24 Q4	3.76B
24 Q3	3.57B
24 Q2	3.43B
24 Q1	3.06B

PE Ratio

CAMRF PE Ratio by quarter
Period	PE Ratio
Sep 26	51.63
Sep 26	51.54
Aug 26	53.91
Aug 26	52.95
Aug 26	53.2
Aug 26	48.4
Jul 26	48.54
Jul 26	49.6
Jul 26	49.28
Jul 26	50.62
Jul 26	51.49
Jun 26	42.8
Jun 26	42.18
Jun 26	42.17
Jun 26	46.06
May 26	47.64
May 26	48.32
May 26	48.7
May 26	47.51
May 26	47.48
Apr 26	47.51
Apr 26	41.04
Apr 26	41.51
Apr 26	42.23
Mar 26	39.82
Mar 26	39.25
Mar 26	39.85
Mar 26	38.52
Feb 26	37.89
Feb 26	40.12
Feb 26	39.42
Feb 26	48.95
Jan 26	48.31
Jan 26	48.47
Jan 26	50.04
Jan 26	49.96
Jan 26	47.24
Dec 25	52.36
Dec 25	48.86
Dec 25	48.81
Dec 25	49.51
Nov 25	49.71
Nov 25	50.25
Nov 25	51.17
Nov 25	44.86
Oct 25	53.54
Oct 25	53.02
Oct 25	53.27
Oct 25	53.66
Oct 25	52.87
Sep 25	69.54
Sep 25	69.61
Sep 25	68.95
Sep 25	69.41
Aug 25	69.92
Aug 25	70.18
Aug 25	72.83
Aug 25	73.01
Aug 25	73.5
Jul 25	72.51
Jul 25	73.67
Jul 25	64.64
Jul 25	64.81
Jun 25	81.94
Jun 25	83.52
Jun 25	87.23
Jun 25	88.74
May 25	68.77
May 25	73.13
May 25	87.24
May 25	86.74
May 25	79.42
Apr 25	79.7
Apr 25	79.16
Apr 25	80.25
Apr 25	82.06
Mar 25	133.61
Mar 25	135.41
Mar 25	135.25
Mar 25	134.74
Feb 25	143.83
Feb 25	120.72
Feb 25	121.29
Feb 25	124.24
Jan 25	126.06
Jan 25	123.95
Jan 25	127.04
Jan 25	127.27
Jan 25	126.04
Dec 24	148.84
Dec 24	149.23
Dec 24	148.43
Dec 24	147.93
Nov 24	164.25
Nov 24	166.4
Nov 24	165.44
Nov 24	163.24
Nov 24	162.72
Oct 24	160.8
Oct 24	172.79

Free Cash Flow Yield

CAMRF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	2.31%
Sep 26	2.31%
Aug 26	2.21%
Aug 26	2.25%
Aug 26	2.24%
Aug 26	2.46%
Jul 26	2.46%
Jul 26	2.4%
Jul 26	2.42%
Jul 26	2.36%
Jul 26	2.32%
Jun 26	2.31%
Jun 26	2.35%
Jun 26	2.35%
Jun 26	2.15%
May 26	2.08%
May 26	2.05%
May 26	2.03%
May 26	2.08%
May 26	2.09%
Apr 26	2.08%
Apr 26	2.41%
Apr 26	2.39%
Apr 26	2.35%
Mar 26	1.93%
Mar 26	1.96%
Mar 26	1.93%
Mar 26	2%
Feb 26	2.03%
Feb 26	1.92%
Feb 26	1.95%
Feb 26	1.57%
Jan 26	1.59%
Jan 26	1.59%
Jan 26	1.54%
Jan 26	1.54%
Jan 26	1.63%
Dec 25	1.64%
Dec 25	1.76%
Dec 25	1.76%
Dec 25	1.73%
Nov 25	1.73%
Nov 25	1.71%
Nov 25	1.68%
Nov 25	1.91%
Oct 25	1.6%
Oct 25	1.62%
Oct 25	1.61%
Oct 25	1.6%
Oct 25	1.62%
Sep 25	0.95%
Sep 25	0.95%
Sep 25	0.96%
Sep 25	0.95%
Aug 25	0.95%
Aug 25	0.94%
Aug 25	0.91%
Aug 25	0.91%
Aug 25	0.9%
Jul 25	0.91%
Jul 25	0.9%
Jul 25	1.03%
Jul 25	1.02%
Jun 25	1.02%
Jun 25	1%
Jun 25	0.96%
Jun 25	0.95%
May 25	1.22%
May 25	1.15%
May 25	0.96%
May 25	0.97%
May 25	1.06%
Apr 25	1.05%
Apr 25	1.06%
Apr 25	1.05%
Apr 25	1.02%
Mar 25	0.85%
Mar 25	0.84%
Mar 25	0.84%
Mar 25	0.85%
Feb 25	0.79%
Feb 25	0.95%
Feb 25	0.94%
Feb 25	0.92%
Jan 25	0.91%
Jan 25	0.92%
Jan 25	0.9%
Jan 25	0.9%
Jan 25	0.91%
Dec 24	1.94%
Dec 24	1.93%
Dec 24	1.94%
Dec 24	1.95%
Nov 24	1.75%
Nov 24	1.73%
Nov 24	1.74%
Nov 24	1.77%
Nov 24	1.77%
Oct 24	1.79%
Oct 24	1.67%

Price to Sales

CAMRF Price to Sales by quarter
Period	Price to Sales
Sep 26	15.72
Sep 26	15.69
Aug 26	16.41
Aug 26	16.12
Aug 26	16.2
Aug 26	14.74
Jul 26	14.78
Jul 26	15.1
Jul 26	15.01
Jul 26	15.41
Jul 26	15.68
Jun 26	13.9
Jun 26	13.7
Jun 26	13.69
Jun 26	14.96
May 26	15.47
May 26	15.69
May 26	15.81
May 26	15.42
May 26	15.42
Apr 26	15.42
Apr 26	13.32
Apr 26	13.48
Apr 26	13.71
Mar 26	13.22
Mar 26	13.03
Mar 26	13.23
Mar 26	12.79
Feb 26	12.58
Feb 26	13.32
Feb 26	13.09
Feb 26	16.25
Jan 26	16.04
Jan 26	16.09
Jan 26	16.61
Jan 26	16.59
Jan 26	15.68
Dec 25	16.59
Dec 25	15.48
Dec 25	15.47
Dec 25	15.69
Nov 25	15.76
Nov 25	15.93
Nov 25	16.22
Nov 25	14.22
Oct 25	16.97
Oct 25	16.8
Oct 25	16.88
Oct 25	17.01
Oct 25	16.76
Sep 25	18.71
Sep 25	18.73
Sep 25	18.55
Sep 25	18.68
Aug 25	18.81
Aug 25	18.88
Aug 25	19.6
Aug 25	19.64
Aug 25	19.77
Jul 25	19.51
Jul 25	19.82
Jul 25	17.39
Jul 25	17.44
Jun 25	18.8
Jun 25	19.16
Jun 25	20.01
Jun 25	20.36
May 25	15.77
May 25	16.78
May 25	20.01
May 25	19.9
May 25	18.22
Apr 25	18.28
Apr 25	18.16
Apr 25	18.41
Apr 25	18.82
Mar 25	21.06
Mar 25	21.34
Mar 25	21.32
Mar 25	21.24
Feb 25	22.67
Feb 25	19.03
Feb 25	19.12
Feb 25	19.58
Jan 25	19.87
Jan 25	19.54
Jan 25	20.02
Jan 25	20.06
Jan 25	19.87
Dec 24	20.85
Dec 24	20.91
Dec 24	20.8
Dec 24	20.73
Nov 24	23.01
Nov 24	23.31
Nov 24	23.18
Nov 24	22.87
Nov 24	22.8
Oct 24	22.53
Oct 24	24.21

EV/EBITDA

CAMRF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	35.32
Sep 26	35.25
Aug 26	37.07
Aug 26	36.33
Aug 26	36.52
Aug 26	32.85
Jul 26	32.95
Jul 26	33.76
Jul 26	33.52
Jul 26	34.54
Jul 26	35.21
Jun 26	28.9
Jun 26	28.43
Jun 26	28.42
Jun 26	31.39
May 26	32.59
May 26	33.11
May 26	33.41
May 26	32.49
May 26	32.47
Apr 26	32.49
Apr 26	27.55
Apr 26	27.92
Apr 26	28.46
Mar 26	27.22
Mar 26	26.79
Mar 26	27.25
Mar 26	26.23
Feb 26	25.74
Feb 26	27.45
Feb 26	26.91
Feb 26	34.22
Jan 26	33.74
Jan 26	33.86
Jan 26	35.06
Jan 26	35
Jan 26	32.91
Dec 25	36.76
Dec 25	34.07
Dec 25	34.04
Dec 25	34.57
Nov 25	34.73
Nov 25	35.15
Nov 25	35.85
Nov 25	31
Oct 25	37.67
Oct 25	37.27
Oct 25	37.47
Oct 25	37.77
Oct 25	37.16
Sep 25	48.5
Sep 25	48.55
Sep 25	48.05
Sep 25	48.4
Aug 25	48.78
Aug 25	48.97
Aug 25	50.97
Aug 25	51.1
Aug 25	51.47
Jul 25	50.73
Jul 25	51.6
Jul 25	44.81
Jul 25	44.94
Jun 25	56.78
Jun 25	57.98
Jun 25	60.77
Jun 25	61.91
May 25	46.85
May 25	50.14
May 25	60.78
May 25	60.4
May 25	54.89
Apr 25	55.09
Apr 25	54.69
Apr 25	55.51
Apr 25	56.87
Mar 25	90.94
Mar 25	92.27
Mar 25	92.15
Mar 25	91.78
Feb 25	98.47
Feb 25	81.43
Feb 25	81.86
Feb 25	84.04
Jan 25	85.38
Jan 25	83.82
Jan 25	86.1
Jan 25	86.27
Jan 25	85.36
Dec 24	100.45
Dec 24	100.74
Dec 24	100.15
Dec 24	99.78
Nov 24	111.72
Nov 24	113.28
Nov 24	112.58
Nov 24	110.97
Nov 24	110.59
Oct 24	109.19
Oct 24	117.96

Price/Operating Cashflow

CAMRF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	36.82
Sep 26	36.76
Aug 26	38.45
Aug 26	37.76
Aug 26	37.95
Aug 26	34.52
Jul 26	34.62
Jul 26	35.37
Jul 26	35.15
Jul 26	36.1
Jul 26	36.72
Jun 26	36.34
Jun 26	35.82
Jun 26	35.81
Jun 26	39.11
May 26	40.45
May 26	41.03
May 26	41.35
May 26	40.34
May 26	40.32
Apr 26	40.34
Apr 26	34.84
Apr 26	35.24
Apr 26	35.85
Mar 26	43.61
Mar 26	42.99
Mar 26	43.64
Mar 26	42.19
Feb 26	41.49
Feb 26	43.94
Feb 26	43.16
Feb 26	53.6
Jan 26	52.91
Jan 26	53.08
Jan 26	54.8
Jan 26	54.71
Jan 26	51.73
Dec 25	53.45
Dec 25	49.87
Dec 25	49.82
Dec 25	50.53
Nov 25	50.75
Nov 25	51.3
Nov 25	52.24
Nov 25	45.79
Oct 25	54.65
Oct 25	54.12
Oct 25	54.38
Oct 25	54.78
Oct 25	53.97
Sep 25	89.63
Sep 25	89.73
Sep 25	88.87
Sep 25	89.47
Aug 25	90.12
Aug 25	90.45
Aug 25	93.87
Aug 25	94.1
Aug 25	94.73
Jul 25	93.46
Jul 25	94.95
Jul 25	83.32
Jul 25	83.53
Jun 25	90.28
Jun 25	92.02
Jun 25	96.1
Jun 25	97.77
May 25	75.76
May 25	80.57
May 25	96.11
May 25	95.56
May 25	87.5
Apr 25	87.81
Apr 25	87.21
Apr 25	88.41
Apr 25	90.41
Mar 25	112.7
Mar 25	114.22
Mar 25	114.08
Mar 25	113.65
Feb 25	121.32
Feb 25	101.82
Feb 25	102.3
Feb 25	104.8
Jan 25	106.33
Jan 25	104.55
Jan 25	107.16
Jan 25	107.35
Jan 25	106.32
Dec 24	51.06
Dec 24	51.2
Dec 24	50.92
Dec 24	50.75
Nov 24	56.35
Nov 24	57.08
Nov 24	56.75
Nov 24	56
Nov 24	55.82
Oct 24	55.16
Oct 24	59.28

Price to Book

CAMRF Price to Book by quarter
Period	Price to Book
Sep 26	7.97
Sep 26	7.96
Aug 26	8.32
Aug 26	8.17
Aug 26	8.21
Aug 26	7.47
Jul 26	7.49
Jul 26	7.66
Jul 26	7.61
Jul 26	7.81
Jul 26	7.95
Jun 26	7.42
Jun 26	7.31
Jun 26	7.31
Jun 26	7.99
May 26	8.26
May 26	8.38
May 26	8.44
May 26	8.24
May 26	8.23
Apr 26	8.24
Apr 26	7.11
Apr 26	7.2
Apr 26	7.32
Mar 26	7.6
Mar 26	7.49
Mar 26	7.6
Mar 26	7.35
Feb 26	7.23
Feb 26	7.66
Feb 26	7.52
Feb 26	9.34
Jan 26	9.22
Jan 26	9.25
Jan 26	9.55
Jan 26	9.53
Jan 26	9.01
Dec 25	9.72
Dec 25	9.07
Dec 25	9.06
Dec 25	9.19
Nov 25	9.23
Nov 25	9.33
Nov 25	9.5
Nov 25	8.33
Oct 25	9.94
Oct 25	9.84
Oct 25	9.89
Oct 25	9.96
Oct 25	9.81
Sep 25	10.92
Sep 25	10.94
Sep 25	10.83
Sep 25	10.9
Aug 25	10.98
Aug 25	11.02
Aug 25	11.44
Aug 25	11.47
Aug 25	11.55
Jul 25	11.39
Jul 25	11.57
Jul 25	10.15
Jul 25	10.18
Jun 25	10.67
Jun 25	10.88
Jun 25	11.36
Jun 25	11.56
May 25	8.95
May 25	9.52
May 25	11.36
May 25	11.3
May 25	10.34
Apr 25	10.38
Apr 25	10.31
Apr 25	10.45
Apr 25	10.69
Mar 25	11.43
Mar 25	11.58
Mar 25	11.57
Mar 25	11.53
Feb 25	12.3
Feb 25	10.33
Feb 25	10.37
Feb 25	10.63
Jan 25	10.78
Jan 25	10.6
Jan 25	10.87
Jan 25	10.89
Jan 25	10.78
Dec 24	11.35
Dec 24	11.38
Dec 24	11.32
Dec 24	11.28
Nov 24	12.52
Nov 24	12.69
Nov 24	12.61
Nov 24	12.45
Nov 24	12.41
Oct 24	12.26
Oct 24	13.17

No video analysis for this stock yet. Request one from our team.

News: CAMRF

prnewswire.com · 17 Jul 2026

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for CAM2029, octreotide extended-release injection, for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of 18 December 2026.

seekingalpha.com · 15 Jul 2026

AI Analysis

Camurus AB

Video analysis: CAMRF

News: CAMRF

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

Camurus AB (publ) (CAMRF) Q2 2026 Earnings Call Transcript

Similar companies